Petros Pharmaceuticals Inc (PTPI)
0.0416 -0.0084 (-16.80%) 13:10 ET [NASDAQ]
0.0414 x 30 0.0423 x 14
Realtime by (Cboe BZX)
0.0414 x 30 0.0423 x 14
Realtime 0.0449 -0.0011 (-) 09:19 ET
for Tue, Apr 15th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -14,319 | -8,163 | -20,038 | -8,987 | -20,586 |
Depreciation Amortization | 5,911 | 3,415 | 13,176 | 6,891 | 6,814 |
Income taxes - deferred | N/A | N/A | N/A | N/A | -1,432 |
Accounts receivable | 1,819 | -144 | 516 | 2,549 | -2,750 |
Accounts payable and accrued liabilities | 616 | -93 | -2,752 | -1,052 | 2,222 |
Other Working Capital | 4,527 | 625 | -3,091 | -1,694 | -5,601 |
Other Operating Activity | -1,156 | -3,266 | -609 | -9,569 | 6,028 |
Operating Cash Flow | $-2,603 | $-7,627 | $-12,797 | $-11,862 | $-15,305 |
Cash Flows From Investing Activities | |||||
PPE Investments | -25 | N/A | N/A | N/A | -5 |
Investing Cash Flow | $-25 | $N/A | $N/A | $N/A | $-5 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | N/A | N/A | N/A | 38,092 |
Debt Repayment | -765 | -1,464 | -1,624 | -7,188 | -6,716 |
Common Stock Issued | N/A | N/A | N/A | 25,757 | 21 |
Other Financing Activity | -6,234 | 13,001 | 0 | 0 | -1,093 |
Financing Cash Flow | $-6,999 | $11,537 | $-1,624 | $18,570 | $30,304 |
Beginning Cash Position | 13,337 | 9,426 | 23,848 | 17,140 | 2,146 |
End Cash Position | 3,710 | 13,337 | 9,426 | 23,848 | 17,140 |
Net Cash Flow | $-9,627 | $3,911 | $-14,421 | $6,708 | $14,994 |
Free Cash Flow | |||||
Operating Cash Flow | -2,603 | -7,627 | -12,797 | -11,862 | -15,305 |
Capital Expenditure | -25 | N/A | N/A | N/A | -5 |
Free Cash Flow | -2,628 | -7,627 | -12,797 | -11,862 | -15,310 |